MAOB and Parkinson disease: Based on all the collective studies, it could be observed that PD treatments remain centralised among several parameters that include mainly α-Syn fibrillation, MAO-B, β-asarone regulation of ER stress pathways, toxicity-induced models with 6-OHDA, MPTP, l-dopa, reserpine, and rotenone with common animal models of rats and mice.